Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1990 1
1991 1
1992 3
1993 2
1994 1
1995 2
1998 1
2000 1
2001 4
2002 1
2003 3
2004 1
2005 3
2006 1
2007 2
2008 3
2009 2
2010 4
2011 4
2012 4
2013 2
2014 3
2015 5
2016 5
2017 7
2018 4
2019 5
2020 10
2021 9
2022 5
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Gynecomastia.
Westenend PJ, Storm R, Oostenbroek RJ. Westenend PJ, et al. N Engl J Med. 2007 Dec 20;357(25):2636; author reply 2636-7. N Engl J Med. 2007. PMID: 18098387 No abstract available.
Sirolimus monotherapy for Erdheim-Chester disease.
van Bommel EFH, van der Zijden MA, Smak Gregoor PJH, Hendriksz TR, Ho-Han SH, Westenend PJ. van Bommel EFH, et al. Among authors: westenend pj. Acta Oncol. 2019 Jun;58(6):901-905. doi: 10.1080/0284186X.2019.1589648. Epub 2019 Mar 28. Acta Oncol. 2019. PMID: 30919713 No abstract available.
Intimal angiosarcoma masquerading as retroperitoneal fibrosis.
van Baalen EA, Hendriksz TR, Brans B, Westenend PJ, van Bommel EFH. van Baalen EA, et al. Among authors: westenend pj. Vasa. 2021 Apr;50(3):240-243. doi: 10.1024/0301-1526/a000889. Epub 2020 Jul 13. Vasa. 2021. PMID: 32657231
Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study.
Baez-Navarro X, van Bockstal MR, Nawawi D, Broeckx G, Colpaert C, Doebar SC, Hogenes MCH, Koop E, Lambein K, Peeters DJE, Sinke RHJA, Bastiaan van Brakel J, van der Starre-Gaal J, van der Vegt B, van de Vijver K, Vreuls CPH, Vreuls W, Westenend PJ, van Deurzen CHM. Baez-Navarro X, et al. Among authors: westenend pj. Mod Pathol. 2023 Jan;36(1):100009. doi: 10.1016/j.modpat.2022.100009. Mod Pathol. 2023. PMID: 36788064
Long-term follow-up of mTOR inhibition for Erdheim-Chester disease.
Pegoraro F, Maniscalco V, Peyronel F, Westenend PJ, Hendriksz TR, Roperto RM, Palumbo AA, Sieni E, Romagnani P, van Bommel EFH, Vaglio A. Pegoraro F, et al. Among authors: westenend pj. Blood. 2020 May 28;135(22):1994-1997. doi: 10.1182/blood.2019004478. Blood. 2020. PMID: 32299103 Free article. No abstract available.
[Revised practice guideline 'Screening and diagnosis of breast cancer'].
Zonderland HM, Tuut MK, den Heeten GJ, Asperen CJ, de Bock GH, Rutqers EJ, Westenend PJ, Smit GM, Benraadt J. Zonderland HM, et al. Among authors: westenend pj. Ned Tijdschr Geneeskd. 2008 Oct 25;152(43):2336-9. Ned Tijdschr Geneeskd. 2008. PMID: 19024064 Review. Dutch.
Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study.
Eijkelboom AH, de Munck L, Menke-van der Houven van Oordt CW, Broeders MJM, van den Bongard DHJG, Strobbe LJA, Mureau MAM, Lobbes MBI, Westenend PJ, Koppert LB, Jager A, Siemerink EJM, Wesseling J, Verkooijen HM, Vrancken Peeters MTFD, Smidt ML, Tjan-Heijnen VCG, Siesling S; NABON-COVID-19 Consortium; COVID and Cancer Care-NL Consortium. Eijkelboom AH, et al. Among authors: westenend pj. Breast Cancer Res Treat. 2023 Jan;197(1):161-175. doi: 10.1007/s10549-022-06732-y. Epub 2022 Nov 5. Breast Cancer Res Treat. 2023. PMID: 36334188 Free PMC article.
95 results